CrushSCI.com
78.1Average days
69Median days
2Fastest days
195Longest days
3492025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

129 days

Ibrutinib dose modification and effectiveness in Japanese patients with chronic lymphocytic leukemia: a post-hoc analysis of the Orbit study

Authors
Yasushi Isobe; Tsuyoshi Muta; Yosuke Masamoto; Go Yamamoto; Shingo Kurahashi; Yoshihiro Kameoka; Shuichi Ota; Eri Matsuki; Kazutaka Ozeki; Takanori Toyama; Naoki Takahashi; Takahiro Kumode; Nobuyuki Aotsuka; Takuro Yoshimura; Hideto Tamura; Ai Omi; Kazuhiro Shibayama; Yuma Fujimori; Kensuke Kojima; Jun Takizawa; Hirokazu Nagai; Junji Suzumiya; Sadao AokiShow moreShow less
Affiliations
1. Department of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital; 2. Department of Transfusion Medicine Clinical Laboratory, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital; 3. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital; 4. Department of Hematology, Toranomon Hospital; 5. Department of Hematology and Oncology, Toyohashi Municipal Hospital; 6. Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine and Faculty of Medicine; 7. Department of Hematology, Akita Red Cross Hospital; 8. Department of Hematology, Sapporo Hokuyu Hospital; 9. Division of Hematology, Department of Medicine, Keio University School of Medicine; 10. Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital; 11. Department of Internal Medicine, Miyazaki Prefectural Nobeoka Hospital; 12. Department of Hematology, International Medical Center, Saitama Medical University; 13. Department of Hematology and Rheumatology, Kindai University Hospital; 14. Department of Hematology and Oncology, Japanese Red Cross Narita Hospital; 15. Department of Hematology, Osaka City General Hospital; 16. Department of Hematology, Dokkyo Medical University Saitama Medical Center; 17. Department of Hematology, Nippon Medical School; 18. Department of Medical Affairs, Johnson & Johnson Innovative Medicine; 19. Statistics & Decision Sciences Japan, Johnson & Johnson Innovative Medicine; 20. Department of Hematology, Kochi Medical School, Kochi University; 21. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine; 22. Department of Hematology, National Hospital Organization Nagoya Medical Center; 23. Department of Hematology, Koga Community Hospital; 24. Department of Medical Technology, Faculty of Medical Technology, Niigata University of Pharmacy and Medical and Life Sciences; 25. Department of Hematology, Niigata Minami HospitalShow moreShow less
Source PDF DOI Publisher page
35 days

Acute promyelocytic leukemia with clonal hematopoiesis: a case study of APL in complete molecular remission transitioning to MDS/MPN and its clinical implications

Authors
Anetta Marcinek; Katrin Schweneker; Manja Meggendorfer; Torsten Haferlach; Frank DickerShow moreShow less
Affiliations
1. MLL Munich Leukemia LaboratoryShow moreShow less
Source PDF DOI Publisher page
64 days

Chronic myelomonocytic leukemia associated with lymphoid neoplasms

Authors
Julia Bannatyne; Iñigo Romon; Juan J. Domínguez; Andrés Insunza; Enrique M. Ocio; Montserrat BrizShow moreShow less
Affiliations
1. Hospital Universitario Marqués de Valdecilla-IDIVAL; 2. Facultad de Medicina, Universidad de CantabriaShow moreShow less
Source PDF DOI Publisher page
82 days

The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia

Authors
Carol Yuk Man Cheung; Nurul Aidah Abdul Halim; Gin Gin Gan; Ying Wang; Hein Than; Jie Jin; Bor Sheng Ko; Soo Min Lim; Wasithep Limvorapitak; Ting Liu; Pak Ling Lui; Melissa Gaik Ming Ooi; Sreekanth Sampath Venkata; Adisak Tantiworawit; Gee Chuan Wong; Su Peng Yeh; Jae-Ho Yoo; Ashley P. NgShow moreShow less
Affiliations
1. Queen Mary Hospital; 2. Singapore General Hospital; 3. University Malaya Medical Centre; 4. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences; 5. First Affiliated Hospital of Zhejiang University College of Medicine; 6. National Taiwan University Hospital; 7. Hospital Sultanah Aminah; 8. Thammasat University Hospital; 9. West China Hospital of Sichuan University; 10. National University Cancer Institute; 11. Tan Tock Seng Hospital; 12. Chiang Mai University Hospital; 13. China Medical University Hospital; 14. Seoul St Mary’s Hospital, The Catholic University of Korea; 15. Peter MacCallum Cancer Centre; 16. The Royal Melbourne HospitalShow moreShow less
Source PDF DOI Publisher page
69 days

Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphoma

Authors
Kacper Kopeć; Mateusz Fałek; Julia Piotrowska; Adrian Ławski; Julia Rojek; Kacper Pawlak; Maria Woźniak; Marta Czajkowska; Olga Raczyńska; Tadeusz Robak; Jan Wojdal; Paweł Robak; Joanna Góra-Tybor; Damian MikulskiShow moreShow less
Affiliations
1. Department of Hemato-Oncology and Internal Medicine, Copernicus Memorial Hospital; 2. Department of Hematology, Medical University of Lodz; 3. Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital; 4. Department of General Hematology and Internal Medicine, Provincial Multi-Specialized Oncology and Trauma Center; 5. Department of Hematology and Transplantology, Copernicus Memorial HospitalShow moreShow less
Source PDF DOI Publisher page
195 days

Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemia

Authors
Lo-Jei Ching; Chia-Hao Wang; Wen-Liang Lo; Yu-Jou Cheng; Huan Ou-Yang; Yuan-Tzu Lan; Pin-I Huang; Yi-Wei Chen; Yen-Hung Yao; Shih-Hwa Chiou; Yi-Ping Yang; Ping-Hsing Tsai; Po-Shen KoShow moreShow less
Affiliations
1. Department of Medical Research, Taipei Veterans General Hospital; 2. Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University; 3. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University; 4. Department of Stomatology, Taipei Veterans General Hospital; 5. Department of Surgery, Taipei Veterans General Hospital; 6. Department of Heavy Particles and Radiation Oncology, Taipei Veterans General Hospital; 7. Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital; 8. Institute of Traditional Medicine, National Yang Ming Chiao Tung University; 9. Division of Hematology, Department of Medicine, Taipei Veterans General HospitalShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does LEUKEMIA & LYMPHOMA take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for LEUKEMIA & LYMPHOMA. The fastest paper went from submission to acceptance in 2 days (The role of radiotherapy in bridging to CAR T-cell therapy for high-grade B-cell lymphoma, received 2026-06-19, accepted 2026-06-21); the slowest took 195 days. The average is 78.1 days and the median is 69 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.